Universidad Peruana Cayetano Heredia

Cost of community-based human papillomavirus self-sampling in Peru: A micro-costing study

Mostrar el registro sencillo del ítem

dc.contributor.author Shin, Michelle B.
dc.contributor.author Garcia Funegra, Patricia Jannet
dc.contributor.author Saldarriaga, Enrique M.
dc.contributor.author Fiestas, José L.
dc.contributor.author Ásbjörnsdóttir, Kristjana H.
dc.contributor.author Iribarren, Sarah J.
dc.contributor.author Barnabas, Ruanne V.
dc.contributor.author Gimbel, Sarah
dc.date.accessioned 2022-04-26T17:26:49Z
dc.date.available 2022-04-26T17:26:49Z
dc.date.issued 2022
dc.identifier.uri https://hdl.handle.net/20.500.12866/11603
dc.description.abstract Background: Cost data of human papillomavirus (HPV) self-sampling programs from low-and-middle-income countries is limited. We estimated the total and unit costs associated with the Hope Project, a community-based HPV self-sampling social entrepreneurship in Peru. Methods: We conducted a micro-costing analysis from the program perspective to determine the unit costs of (1) recruitment/training of community women (Hope Ladies); (2) Hope Ladies distributing HPV self-sampling kits in their communities and the laboratory testing; and (3) Hope Ladies linking screened women with follow-up care. A procedural manual was used to identify the program's activities. A structured questionnaire and in-depth interviews were conducted with administrators to estimate the resource/time associated with activities. We obtained unit costs for each input previously identified from budgets and expenditure reports. Findings: From November 2018 to March 2020, the program recruited and trained 62 Hope Ladies who distributed 4,882 HPV self-sampling kits in their communities. Of the screened women, 586 (12%) tested HPV positive. The annual cost per Hope Lady recruited/trained was $147·51 (2018 USD). The cost per HPV self-sampling kit distributed/tested was $45·39, the cost per woman followed up with results was $55·64, and the cost per HPV-positive woman identified was $378·14. Personnel and laboratory costs represented 56·1% and 24·7% of the total programmatic cost, respectively. Interpretation: Our findings indicate that implementation of a community-based HPV self-sampling has competitive prices, which increases its likelihood to be feasible in Peru. Further economic evaluation is needed to quantify the incremental benefits of HPV self-sampling compared to more established options such as Pap tests. en_US
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartofseries Lancet Regional Health. Americas
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Peru en_US
dc.subject Micro-costing en_US
dc.subject Cervical cancer prevention en_US
dc.subject HPV self-sampling en_US
dc.title Cost of community-based human papillomavirus self-sampling in Peru: A micro-costing study en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1016/j.lana.2021.100160
dc.relation.issn 2667-193X


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas